找回密码
 注册

微信登录,快人一步

QQ登录

只需一步,快速开始

公告区+ 发布

03-10 08:57
03-06 08:48
03-06 08:48
02-17 16:11
02-17 16:10
01-07 16:18
01-06 15:55
01-02 17:30
查看: 1882|回复: 0

艰难梭菌毒素检测试剂盒的诊断能力系统评价

[复制链接]
发表于 2008-11-23 22:58 | 显示全部楼层 |阅读模式

马上注册登录,享用更多感控资源,助你轻松入门。

您需要 登录 才可以下载或查看,没有账号?注册 |

×

                               
登录/注册后可看大图

Volume 8, Issue 12, December 2008, Pages 777-784

Review Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review
艰难梭菌毒素检测试剂盒的诊断能力系统评价

Tim Planche MDa, b, Adamma Aghaizu MScc, Richard Holliman MDa, b, Peter Riley MDa, b, Jan Poloniecki DPhilc, Aodhán Breathnach FRCPatha, b, d and Prof Sanjeev Krishna ScDb, ,
aDepartment of Medical Microbiology, St George's Hospital, London, UK
bCentre for Infection, Division of Cellular and Molecular Medicine, St George's University of London, London, UK
cDepartment of Community Health Sciences, St George's University of London, London, UK
dHealth Protection Agency Collaborating Centre, Department of Medical Microbiology, St George's Hospital, London, UK


Available online 1 November 2008.


SummaryClostridium difficile can be a fatal hospital-acquired infection and its prevalence has increased. Accurate diagnosis of C difficile is essential for patient management, infection control, and for defining its epidemiology. We did a systematic review of commonly used commercial assays for detection of C difficile toxin (CDT) A and B in stool samples. By comparison of detection of CDT in cell culture with or without selective culture for C difficile, the median sensitivities and specificities (IQR) were as follows: Meridian Premier 0·95 (0·86–0·97) and 0·97 (0·95–0·98), TechLab Tox A/B II 0·83 (0·82–0·85) and 0·99 (0·98–1·00), TechLab Tox A/B Quik Chek 0·84 (0·81–0·87) and 1·00 (0·99–1·00), Remel Xpect 0·82 (0·75–0·89) and 0·96 (0·95–0·98), Meridian Immunocard 0·90 (0·84–0·92) and 0·99 (0·98–1·00), and BioMérieux VIDAS 0·76 and 0·93. If the prevalence of CDT A and B in stool samples is relatively low (<10%), the positive predictive value of these assays is unacceptably low (eg, <50% in some circumstances) and will vary depending on the assay and number of samples tested. This low positive predictive value impinges on clinical management, outbreaks, and makes epidemiological data unreliable. To improve diagnosis, we suggest a two-stage testing strategy for C difficile toxin with an initial highly sensitive rapid screening test to identify positive samples that are then confirmed by a reference method.

Article OutlineIntroduction Methods Performance characteristics of tests Data source Study eligibility Data extraction and quality assessment Statistical analysisResults Discussion Search strategy and selection criteria References

Diagnosis of Clostridium difficile infection .pdf (206.25 KB, 下载次数: 4)

评分

参与人数 1 +10 收起 理由
绿叶 + 10 很好的资料与话题

查看全部评分

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册 |

本版积分规则

快速回复 返回顶部 返回列表